Clinical Trials Browser

Phase 2 × Squamous Cell Carcinoma of Head and Neck × Fenretinide × Clear all

NCT00006471 2018-11-01

Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms